Rheumatology International, Journal Year: 2023, Volume and Issue: 43(9), P. 1583 - 1595
Published: June 20, 2023
The current systematic review aimed to document published cases of femoral head avascular necrosis (FHAVN) post-COVID-19, report the COVID-19 disease characteristics and management patients received, evaluate how FHAVN were diagnosed treated among various reports. A literature was performed per Preferred Reporting Items for Systematic Reviews Meta-Analyses (PRISMA) guidelines through a comprehensive English search on January 2023 four databases (Embase, PubMed, Cochrane Library, Scopus), including studies reporting post-COVID-19. Fourteen articles included, ten (71.4%) case reports, (28.6%) series reported 104 having mean age 42.2 ± 11.7 (14:74) years, in which 182 hip joints affected. In 13 corticosteroids used during plan 24.8 11 (7:42) days, with prednisolone equivalent dose 1238.5 492.8 (100:3520) mg. 142.1 107.6 (7:459) days passed between diagnosis detection, most hips stage II (70.1%), concomitant septic arthritis present eight (4.4%) hips. Most (147, 80.8%) non-surgically, 143 (78.6%) received medical treatment, while 35 (19.2%) surgically managed, 16 (8.8%) core decompression, (7.1%) primary THA, five (2.7%) staged THA three (1.6%) had first (debridement application antibiotic-loaded cement spacer). outcomes acceptable as regards function pain relief. Femoral post-COVID-19 infection is real concern, primarily attributed corticosteroid usage, besides other factors. Early suspicion detection are mandatory, conservative lines effective early stages outcomes. However, surgical intervention required progressive collapse or presented late stage.
Language: Английский